| Literature DB >> 35913019 |
Lili Qu1,2, Bingqian Lin1,2, Wenping Zeng1,2, Chunhong Fan1,2, Haotian Wu1,2, Yushu Ge1, Qianqian Li1,2, Canjun Li1,2, Yanan Wei1,2, Jing Xin1, Xingbing Wang3, Dan Liu1, Chunlei Cang1,2.
Abstract
Lysosomes are degradative organelles and play vital roles in a variety of cellular processes. Ion channels on the lysosomal membrane are key regulators of lysosomal function. TMEM175 has been identified as a lysosomal potassium channel, but its modulation and physiological functions remain unclear. Here, we show that the apoptotic regulator Bcl-2 binds to and inhibits TMEM175 activity. Accordingly, Bcl-2 inhibitors activate the channel in a caspase-independent way. Increased TMEM175 function inhibits mitophagy, disrupts mitochondrial homeostasis, and increases production of reactive oxygen species (ROS). ROS further activates TMEM175 and thus forms a positive feedback loop to augment apoptosis. In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (PD), knockout (KO) of TMEM175 mitigated motor impairment and dopaminergic (DA) neuron loss, suggesting that TMEM175-mediated apoptosis plays an important role in Parkinson's disease (PD). Overall, our study reveals that TMEM175 is an important regulatory site in the apoptotic signaling pathway and a potential therapeutic target for Parkinson's disease (PD).Entities:
Keywords: Parkinson's disease; TMEM175; apoptosis; lysosome; potassium channel
Mesh:
Substances:
Year: 2022 PMID: 35913019 PMCID: PMC9442313 DOI: 10.15252/embr.202153234
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 9.071